Ron Johnson

Person

Last mentioned: 5d ago

Timeline

  1. Initial Inquiry

    The Senator's office begins requesting data on DMD drug approval timelines and internal CBER deliberations.

  2. Investigation Announced

    Sen. Ron Johnson announces a formal probe into the FDA's handling of rare disease drug applications.

  3. Commissioner Meeting

    Johnson meets with FDA Commissioner Marty Makary to discuss specific biologic therapy rejections.

Stories mentioning Ron Johnson 1

pharma Neutral

GOP Senator Probes FDA Over Rare Disease Drug Rejections

Senator Ron Johnson (R-Wisc.) has launched an investigation into the FDA's regulatory hurdles for rare disease treatments, specifically targeting biologics for Duchenne muscular dystrophy. The probe follows a direct meeting with FDA Commissioner Marty Makary and signals a significant escalation in political pressure on the agency's approval standards.

2 sources